On July 16th, Medicare or CMS (Centers for Medicare and Medicaid Services) proposed a major change to their coverage for proton therapy called the Radiation Oncology Alternative Payment Model or RO APM. This proposed ruling would include proton therapy to be reimbursed at the same rate as other radiation therapies without regard to cost and resource differentials. This change could result in a negative impact by restricting patient access to proton therapy.
- Proton centers will be challenged to serve patients under the RO APM.
- The RO APM would restrict and jeopardize Medicare beneficiaries’ access to proton therapy.
- The RO APM would threaten access to proton therapy for children who benefit most.
- The RO APM would not support innovation such as proton therapy treatment and research.
We can influence a positive change for future cancer patients. Please help us ensure future cancer patients have access to proton therapy as a treatment option.